GenomeWeb Publishes In-Depth On CureMatch’s Genomic Therapy-Matching Business
CureMatch has been featured in GenomeWeb’s recent in-depth article, “CureMatch Building Genomic Therapy-Matching Business Focused on Drug Combinations.” The article discusses CureMatch’s innovative product, which guides oncologists in the selection of cancer drugs customized for individual patients based on genomics. The product considers more than 4.5 million different cancer treatment options, including combinations of drugs.
NEW YORK (GenomeWeb) – A newcomer to the genomic medicine field, CureMatch, announced earlier this year that it had closed a bridge round to Series A financing with Serra Ventures after launching its genomics-based therapy-matching service this spring.
The company’s COO Stephane Richard said in an interview this week that CureMatch hasn’t disclosed details of the Serra financing yet, but the firm’s business strategy involves an initial focus on marketing its analysis directly to patients and doctors while working on pilot studies with genomics providers that may later lead to white-label type agreements that integrate its analysis into their own reports. View the full article at GenomeWeb.
GenomeWeb is an independent online news organization based in New York. GenomeWeb serves the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and molecular diagnostics.
GenomeWeb’s editorial mission is to cover the scientific and economic ecosystem spurred by the advent of high-throughput genome sequencing. We operate the largest online newsroom focused on advanced molecular research tools in order to provide our readers with exclusive news and in-depth analysis of this rapidly evolving market.
GenomeWeb users are found in major scientific organizations around the world, including biopharmaceutical companies, research universities, biomedical institutes, clinical labs, and government laboratories. Our advertisers include leading suppliers of research tools, analytical instruments, information technology, and molecular diagnostics.